Printer Friendly

Printed from http://www.researchandmarkets.com/reports/1322838

InNexus Biotechnology Inc. (IXS) - Strategic Analysis Review

Description:
InNexus Biotechnology Inc. (InNexus) is a development stage biotechnology company focused on the development of the next generation of monoclonal antibodies using its Dynamic Cross-linking (DXL) technology. The DXL technology seeks to improve the therapeutic potency of existing monoclonal antibody products by increasing the binding to target antigen, enhancing antibody effect or functions and installing new properties into antibodies. The company is developing its first product DXL625, and pursuing additional collaborative development arrangements. It is also preparing for the launch of its second proposed DXL product. It is headquartered in Vancouver, British Columbia of Canada.

InNexus Biotechnology Inc. Key Recent Developments

Jul 01, 2010: InNexus Amends Collaborative Agreement With NCI
Jun 29, 2010: InNexus Develops New Protein For AMD Eye Disorder
May 27, 2010: InNexus Signs Collaboration Agreement With NCI
Mar 23, 2010: InNexus Bio Announces Publication Of DXL625 Data In Journal Of Anti-Cancer Drugs
Jan 05, 2010: InNexus Develops New Psoriasis Product

Our InNexus Biotechnology Inc. - Strategic Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Our summarization of the company’s business strategy.
- SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities - A list of key manufacturing facilities of the company.

Note-: Some sections may be missing if data is unavailable for the company.

Reasons to buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with Our detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
 
Contents:



List of Tables
Section 1 - About the Company
InNexus Biotechnology Inc. - Key Facts
InNexus Biotechnology Inc. - Key Employees
InNexus Biotechnology Inc. - Key Employee Biographies
InNexus Biotechnology Inc. - Major Products and Services
InNexus Biotechnology Inc. - History
InNexus Biotechnology Inc. - Company Statement
InNexus Biotechnology Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 - Company Analysis
InNexus Biotechnology Inc. - Business Description
InNexus Biotechnology Inc. - SWOT Analysis
SWOT Analysis - Overview
InNexus Biotechnology Inc. - Strengths
Strength - Sturdy Research and Development Activities
Strength - Focus on developing monoclonal antibodies (MAb) th
InNexus Biotechnology Inc. - Weaknesses
Weakness - Lack of proper corporate governance
Weakness - Lack of marketable products
InNexus Biotechnology Inc. - Opportunities
Opportunity - Strategic collaboration and agreements
Opportunity - Biotech Focus
Opportunity - Changing Demographics
Opportunity - Emerging markets
InNexus Biotechnology Inc. - Threats
Threat - Government Regulations
Threat - Uncertain R&D Outcomes
Threat - Competitive Pressures
InNexus Biotechnology Inc. - Key Competitors
Section 3 - Company’s Recent Developments
Jul 01, 2010: InNexus Amends Collaborative Agreement With NCI
Jun 29, 2010: InNexus Develops New Protein For AMD Eye Disorder
May 27, 2010: InNexus Signs Collaboration Agreement With NCI
Mar 23, 2010: InNexus Bio Announces Publication Of DXL625 Data In Journal Of Anti-Cancer Drugs
Jan 05, 2010: InNexus Develops New Psoriasis Product
Jul 10, 2009: InNexus, Genhelix Sign Letter of Intent
Section 4 - Appendix
Methodology
About Us
Contact Us
Disclaimer
 
Companies Mentioned
InNexus Biotechnology Inc. (InNexus) is a development stage biotechnology company focused on the development of the next generation of monoclonal antibodies using its Dynamic Cross-linking (DXL) technology. The DXL technology seeks to improve the therapeutic potency of existing monoclonal antibody products by increasing the binding to target antigen, enhancing antibody effect or functions and installing new properties into antibodies. The company is developing its first product DXL625, and pursuing additional collaborative development arrangements. It is also preparing for the launch of its second proposed DXL product. It is headquartered in Vancouver, British Columbia of Canada.
 
Ordering:
Order Online - visit http://www.researchandmarkets.com/reports/1322838

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

 
Page 1 of 2
Printed Oct 25th 2014
5:34:38 PM

Fax order form

To place a fax order simply print this form, fill in and fax the completed form to the number below. If you have any questions please email help@researchandmarkets.net

Order information

Please verify that the product information is correct and select the format you require.

Product name

InNexus Biotechnology Inc. (IXS) - Strategic Analysis Review

Web Address

http://www.researchandmarkets.com/reports/1322838

Office Code

SCOI7T

 

Report Formats

Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User USD 125
Electronic (PDF) - Site License USD 250
Electronic (PDF) - Enterprisewide USD 375

Contact information

Please enter all the information below in block capitals.

Title:
Mr Mrs Dr Miss Ms Prof
First Name:
Last Name:
Email Address:
Job Title:
Organisation:
Address:
City:
Postal / Zip Code:
Country:
Phone Number:
Fax Number:

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Page 2 of 2
Printed Oct 25th 2014
5:34:38 PM

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

Pay by Credit Card:

American Express

Diners Club

Master Card

Visa

Cardholder's Name:
Cardholder's Signature:
Expiry Date:
/
Card Number:
CVV Security Code:
Issue date:
/ (Diners Club only)
 
Pay by Check:

Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

 
Pay by Wire Transfer:

Please transfer funds to:

Account Number:
83313083
Sort Code:
98-53-30
Swift Code:
ULSBIE2D
IBAN Number:
IE78ULSB98533083313083
Bank Address:
Ulster Bank,
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.
 

If you have a Marketing Code please enter it below:

Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)